1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea Pace is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

The influence of patient sex on clinical approaches to malignant glioma

Matteoni, S., Abbruzzese, C., Villani, V., Malorni, W., Pace, A., Matarrese, P. & Paggi, M. G., Jan 1 2020, In : Cancer Letters. 468, p. 41-47 7 p.

Research output: Contribution to journalShort survey

Open Access
  • A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

    Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

    Research output: Contribution to journalArticle

  • A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

    Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 1 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

    Research output: Contribution to journalArticle

  • Comorbidities in elderly patients with glioblastoma: A field-practice study

    Villani, V., Tanzilli, A., Telera, S. M., Terrenato, I., Vidiri, A., Fabi, A., Zucchella, C., Carapella, C. M., Marucci, L., Casini, B., Carosi, M., Oppido, P. M. & Pace, A., Mar 2019, In : Future Oncology. 15, 8, p. 841-850 10 p.

    Research output: Contribution to journalArticle

  • Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016

    Rudà, R., Pellerino, A., Pace, A., Carapella, C. M., Dealis, C., Caroli, M., Faedi, M., Bello, L., Migliore, E., Marchese, G., Bertero, L., Cassoni, P. & Soffietti, R., 2019, In : Journal of Neuro-Oncology. 145, 1, p. 115-123 9 p.

    Research output: Contribution to journalArticle